Keith L. Lui
Corporate Officer/Principal bij DURECT CORPORATION
Profiel
Keith L.
Lui is currently working as the SVP-Business Development & Medical Affairs at DURECT Corp.
Prior to this, he held the position of Vice President-Marketing at Pharmacyclics LLC.
From 2014 to 2017, he served as the Vice President-Marketing at Versartis, Inc. Mr. Lui completed his undergraduate degree at the University of California, Berkeley and obtained an MBA from Vanderbilt Owen Graduate School of Management.
Actieve functies van Keith L. Lui
| Bedrijven | Functie | Begin |
|---|---|---|
| DURECT CORPORATION | Corporate Officer/Principal | 01-05-2020 |
Eerdere bekende functies van Keith L. Lui
| Bedrijven | Functie | Einde |
|---|---|---|
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Verkoop & Marketing | 01-07-2017 |
| PHARMACYCLICS, INC. | Verkoop & Marketing | - |
Opleiding van Keith L. Lui
| University of California, Berkeley | Undergraduate Degree |
| Vanderbilt Owen Graduate School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
